Q3 2024 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day and welcome to the Q3 FY '24 earnings conference call of Alembic Pharmaceuticals Limited. We have with us today Mr. Pranav Amin, Managing Director; Mr. R. K. Baheti, Director of Finance and CFO; Mr. Mitanshu Shah, Head of Finance; and Mr. Ajay Kumar Desai, Senior Vice-President of Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R. K. Baheti. Thank you and over to you, sir.
&
Thank you. Good afternoon, I thank everyone to join our Q3 Regions call. Straight away, I will go to financials. During the quarter, our total revenue for the company grew by 8% to INR 1,631 crores. EBITDA also boomed up and is INR 269 crores, which is 16.5% of sales and net profit grew by 48% to INR 180 crores. During the nine-month period, I mean the cumulative up to December 2023, our revenue grew 11% to INR 4,712 crores. EBITDA is INR 697 crores, which is 15% of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
